The manuscript preparation guidelines are adapted from those developed for the International Committee of Medical Journal Editors. Careful attention to these guidelines will help ensure that your manuscript will move through the peer-review process smoothly and quickly.
For better publicity of your work, obtain an ORCID identifier and send it along with your publication. ORCID provides a persistent digital identifier that distinguishes you from all other researchers and, through integration into key research workflows, such as submitting manuscripts and grants, accepts automated links between you and your professional activities, ensuring that Your work is recognized. Have more information.

Cover Letter

A cover letter is essential and must be submitted with the manuscript (approximately one-page cover). Include the following in the cover letter:
State in the letter that:
You wish to submit the paper for the consideration for publication in Bionatura journals;
  • The manuscript is being sent by the corresponding author on behalf of all authors;
  • It presents the original work of the authors;
  • Identical or similar work has not been published or submitted for publication elsewhere;
  • All the authors made a significant contribution to the study; and
  • All the authors have read and approved the final version of the manuscript.
  • Briefly summarizes why your paper is a worthy contribution to the scientific literature;
  • If the document is presented at a meeting or conference, specify the complete name of the meeting, the city where it was held, and the exact date on which the paper was presented.
  • Relates your submission to previously published work;
  • Specifies the type of article you are submitting (see Article Types & Format);
  • The name of the corresponding author with contact address, contact phone number, email, and fax number (if available) must be listed.
  • The covering letter should be signed by the corresponding author on behalf of all authors.


Bionatura does not have restrictions on manuscript length. There are no specific restrictions for the number of words, figures, or the range of the supporting information, although we encourage a concise and accessible writing style. We do, however, help you to employ a clear and concise writing style. If you believe your manuscripts would benefit from professional editing, we encourage you to utilize a copyediting service—or ask a colleague whose native language is English for assistance
All submissions should begin with the following sections: 


Your manuscript must be submitted with both a full title and a short title, which will appear at the top of the PDF upon publication if accepted. Only the full title should be included in the manuscript file; the short title will be entered during the online submission process.
Your article title should be concise, accurate, and informative. Titles are often used by search engines and other information retrieval systems. The title should be specific, and it should contain words that readers might be searching for.
This will make it more likely that people will find and read your article. The title must reflect the content of your essay; if it does not, readers will be confused or disappointed. The title must also be understandable to the general reader outside your field where possible, avoid abbreviations, formulae, and numbers.
The full title must be 150 characters or fewer and set in sentence case (the first word only and proper nouns capitalized). It should be specific, descriptive, concise, and understandable to readers outside the subject field. The short title should be 50 characters
or fewer and should state the topic of the paper. Authors who hold patents related to the research presented in the manuscript should include a statement in a footnote

Authorship and affiliation

All persons designated as authors should qualify for writing, and all those who are eligible should be listed. Those who contributed to the work but do not qualify for authorship should be listed in the acknowledgments. When a large group or center has conducted the work, the author list should include the individuals whose contributions meet the criteria defined above, as well as the group name.
All author names should be listed in the following order:

  • First names (or initials, if used),
  • Middle names (or initials, if used), and
  • Last names (surname, family name)
Each author should list a Highest academic qualification, academic position in the associated department, university, or organizational affiliation and its location, including city, state/province (if applicable), and country. If the article has been submitted on behalf of a consortium, all author names and affiliations should be listed.
One author should be designated (with an asterisk) as the corresponding author, and his or her contact address, contact phone number, email, and fax number should be included on the manuscript cover page. This information will be published with the article is accepted. No changes to affiliation can be made after the article is accepted.


Your abstract is what readers will use when they are deciding whether to read your article. For this reason, your summary is , and you should spend time making sure that it is readable and that it contains a complete description of your research.
In approximately 100-300 words, you will need to summarize your findings and what the implications of those findings are.
The abstract must be accurate as a reflection of what is in your article.
  • Because abstracts are the only substantive portion of the article indexed in many electronic databases, and the single piece many readers read, authors need to be careful that summaries reflect the content of the article accurately. It should emphasize new and important aspects of the study or observations.
  • Please do not include citations in your abstract and avoid the use of abbreviations, if possible and must be self-contained.
  • It is an excellent idea to include keywords in your abstract, as this will help readers to find it. Key phrases need to make sense within the abstract. Try to keep to a maximum of three or four different keyword phrases, and avoid over-repetition of such phrases as this can look like an attempt to trick a search engine, which may result in a page being rejected.
  • Check that the abstract reads well.
  • For papers reporting original research, state the primary objective and any hypothesis tested; describe the research design and your reasons for adopting that methodology; state the methods and procedures employed, indicate the primary outcomes and results, and state the conclusions that might be drawn from these data and results, including their implications for further research or application/practice.
  • For review papers, indicate the primary objective of the review; the reasoning behind your literature selection; and the way you critically analyze the literature; state the primary outcomes and results of your study; and state the conclusions that might be drawn, including their implications for further research or application/practice.


Keywords can be up to 6, which may include the species, variables tested, and the primary response criteria. The first letter of each keyword is lowercase (unless a proper noun); keywords are separated by commas and presented in alphabetical order, and no abbreviations should be used. Keywords will assist indexers in cross-indexing the article and may be published with the abstract.


Use only standard abbreviations; the use of non-standard abbreviations can be extremely confusing to readers. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
All submissions should end with the sections of:
The International Committee of Medical Journal Editors has recommended the following criteria for authorship; these criteria are still appropriate for those journals that distinguish authors from other contributors.

Byline Authors

An «author» is generally considered to be someone who has made substantive intellectual contributions to a published study, and biomedical authorship continues to have important academic, social, and financial implications.
  • Editors are strongly encouraged to develop and implement a contributorship policy, as well as a system on identifying who is responsible for the integrity of the work as a whole.
  • While contributorship and guarantor ship policies remove much of the ambiguity surrounding contributions, it leaves unresolved the question of the quantity and quality of participation that qualify for authorship.
  • Authorship credit should be based on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to act as guarantor of the work (ensuring that questions related to any part of the work are appropriately investigated and resolved). Authors should meet conditions 1, 2, 3 and 4.
  • When a large, multi-center group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship defined above, and editors will ask these individuals to complete journal-specific author and conflict of interest disclosure forms. When submitting a group author manuscript, the corresponding author should indicate the preferred citation and should identify all individual authors as well as the group name. Journals will generally list other members of the group in the acknowledgments. The National Library of Medicine indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript.
  • Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.
  • All persons designated as authors should qualify for writing, and all those who are eligible should be listed.
  • Each author should have participated sufficiently in work to take public responsibility for appropriate portions of the content.
  • Increasingly, authorship of multi-center trials is attributed to a group. All members of the group who are named as authors should fully meet the above criteria for authorship.
  • The order of authorship on the byline should be a joint decision of the co-authors. Authors should be prepared to explain the order in which authors are listed.

Contributors Listed in Acknowledgments

  • All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Financial and material support should also be acknowledged.
  • Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under a heading such as «clinical investigators» or «participating investigators,» and their function or contribution should be described — for example, «served as scientific advisors,» «critically reviewed the study proposal,» «collected data,» or «provided and cared for study patients.»
  • Because readers may infer their endorsement of the data and conclusions, all persons must give written permission to be acknowledged. 


In this section acknowledge anyone who contributed towards the study by making substantial contributions to conception, materials essential for the research, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for relevant intellectual content, but who does not meet the criteria for authorship. In acknowledging the assistance of colleagues, it is expected that you will have obtained their permission to be named. If the text and/or figures are being reprinted with the permission of an author or publisher, acknowledge them in this section.
Funding sources should not be included in the acknowledgments, or anywhere in the manuscript file. You will provide this information during the manuscript submission process.

Funding information

Please provide a list of the sources of funding, as well as the relevant grant numbers, where possible. List the authors associated with specific funding sources.

Competing interest

Authors are responsible for recognizing and disclosing conflicts of interest that might bias their work. They should acknowledge in the manuscript all financial support for the work and other personal connections. Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read ‘The author(s) declare that they have no competing interests’. When completing your declaration, please consider the following questions: 

Financial competing interests

In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, ¿either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.
Do you hold any stocks or shares in an organization that may in any way, gain or lose financially from the publication of this manuscript, ¿either now or in the future? If so, please specify
Do you hold, ¿or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the paper? If so, please specify.
Do you have any other financial competing interests? If so, please specify.

Non-financial competing interests

Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial, ¿or any other) to declare about this manuscript? If so, please specify.
If you are unsure as to whether you or one your co-authors, has a competing interest, please discuss it with the editorial office.


  • References are listed in numerical order, and in the same order in which they are cited in the text. The reference list appears at the end of the paper.
  • Use superscript Arabic numerals to cite material, e.g., 1 The first reference used in a written document is listed as 1 in the reference list.
  • Begin your reference list on a new page and title it ‘References.’
  • The reference list should include all and only those references you have cited in the text. (However, do not include unpublished items such as correspondence).
  • Use Arabic numerals (1, 2, 3, 4, 5, 6, 7, 8, 9).
  • Abbreviate journal titles in style used in the NLM Catalog
  • Check the reference details against the actual source – you are indicating that you have read a source when you cite it.
  • Be consistent with your referencing style across the document.
  • For secure handling of the bibliographical references we advise the use of Mendeley and install our style Bionatura

Supplemental materials

Although we do not limit the number or type of Supplemental Material items authors may include, we do require that they provide a relevant and useful expansion of the article and that they be as well described as are figures and tables included within the body of the article. Good metadata of this material are essential to discoverability and usefulness. All Supplemental Material should consist of the following:
Type and number: Supplemental material can be named in almost any way, provided that the files are consistently named with numbers with a period. Examples:
  • Figure 1.
  • Table 1.
  • Text 1.
  • Video 1.
  • Animation 1.
  • Alternative Language Abstract 1.
Figures, Tables, Videos, Animations should be provided with titles should be no more than 15 words and set in bold type, using sentence case.
Supplemental material figures and tables should follow the requirements for main-text figures and tables (see Figure Preparation and Table Preparation).
Other types of supplementary material files should include a caption of no more than 300 words, should be describing the key message of the figure/video/animation in such a way that readers can interpret the file without referring to the text.


Tables capture information concisely, and display it efficiently; they also provide information at any desired level of detail and precision. Including data in tables rather than text frequently makes it possible to reduce the length of the text.
Type or print each table with double spacing on a separate sheet of paper. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Do not use internal horizontal or vertical lines. Give each column a short or abbreviated heading. Authors should place explanatory matter in footnotes, not in the heading. Explain in footnotes all nonstandard abbreviations. For footnotes use the following symbols, in sequence:
Identify statistical measures of variations, such as standard deviation and standard error of the mean.
Be sure that each table is cited in the text.
If you use data from another published or unpublished source, obtain permission, and acknowledge them fully.
Additional tables containing backup data too extensive to publish in print may be appropriate for publication in the electronic version of the journal, deposited with an archival service, or made available to readers directly by the authors. In that event, an appropriate statement will be added to the text. Submit such tables for consideration with the paper so that they will be available to the peer reviewers. Please consult Table Preparation for detailed guidelines on formatting tables.


Figures should be either professionally drawn and photographed, or submitted as photographic quality digital prints. In addition to requiring a version of the figures suitable for printing, some journals now ask authors for electronic files of figures in a format (e.g., JPEG or GIF) that will produce high quality images in the web version of the journal; authors should review the images of such files on a computer screen before submitting them, to be sure they meet their own quality standard.
For x-ray films, scans, and other diagnostic images, as well as pictures of pathology specimens or photomicrographs, send sharp, glossy, black-and-white or color photographic prints, usually 127 x 173 mm (5 x 7 inches). Although some journals redraw figures, many do not. Letters, numbers, and symbols on Figures should, therefore, be bright and even throughout, and of sufficient size that when reduced for publication, each item will still be legible. Figures should be made as self-explanatory as possible since many will be used directly in slide presentations. Titles and detailed explanations belong in the legends, however, not on the illustrations themselves.
Photomicrographs should have internal scale markers. Symbols, arrows, or letters used in photomicrographs should contrast with the background.
If photographs of people are used, either the subjects must not be identifiable, or their pictures must be accompanied by written permission to use the picture. Whenever possible permission for publication should be obtained.
Figures should be numbered consecutively according to the order in which they have been first cited in the text. If a figure has been published, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. Permission is required irrespective of authorship or publisher except for documents in the public domain.
For illustrations in color, ascertain whether the journal requires color negatives, positive transparencies, or color prints. Accompanying drawings marked to indicate the region to be reproduced might be useful to the editor.
Please consult Figure Preparation for detailed guidelines.

Legends of figures

Type or print out legends for illustrations using double spacing, starting on a separate page, with Arabic numerals corresponding to the drawings. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Explain the internal scale and determine the method of staining in photomicrographs.

Units of measurements

Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples.
Temperatures should be in degrees Celsius. Blood pressures should be in millimeters of mercury unless the journal specifically requires other units.
Journals vary in the units they use for reporting hematological, clinical chemistry, and other measurements. Authors must consult the information for authors for the particular journal and should report laboratory information in both the local and International System of Units (SI). Editors may request that the authors before publication add alternative or non-SI units since SI units are not universally used. Drug concentrations may be reported in either SI or mass units, but the alternative should be provided in parentheses where appropriate.

Submission with equations

In both displayed equations and in text, scalar variables must be in italics, with non-variable matter in upright type.
Displayed equations referred to in the text should be numbered serially ((1), (2), etc.) on the right-hand side of the page. Short expressions not referred to by any number will usually be incorporated in the text.
Mathematical equations should preferably be typewritten, with subscripts and superscripts clearly shown. It is helpful to identify unusual or ambiguous symbols in the margin when they first occur. Please ensure all symbols are described in the text. If equations are numbered, consecutive Arabic numbers in parentheses should be used. Equations may be referred to in the text as «equation (1)», «equations (2)-(4)». To simplify typesetting, please use: (1) the «exp» form of complex exponential functions; (2) fractional exponents instead of root signs; and (3) the solidus (/) to simplify fractions, e.g. 3/4, exp x½. Other letters not marked will be set in roman type. Please supply reproducible artwork for equations containing ring formulae and other complex chemical structures. Schemes should also be numbered with consecutive Arabic numbers.
If you are submitting your manuscript as a Word-processed document, please ensure that equations are editable (i.e., not an image or locked). If using an equation editor, do not save the equations in a non-editable format. 

Submission with mathematical scripts

Special care should be taken with mathematical scripts, especially subscripts and superscripts and differentiation between the letter «ell» and figure one, and the letter «oh» and the figure zero.
If your keyboard or PC does not have the characters you need, or when using longhand, it is essential to differentiate between K and k; X, x, and x (multiplication); asterisks intended to appear when published as multiplication signs and those expected to remain as asterisks; etc.
Special symbols and others used to stand for symbols not available in the character set of your PC, should be highlighted in the text and explained in the margin. In some cases it is helpful to supply annotated lists of symbols for the guidance of the sub-editor and the typesetter, and a Nomenclature section preceding the Introduction.
In both displayed equations and text, scalar variables must be in italics, with the non-variable matter in upright type. For simple fractions in the text, the solidus «/» should be used instead of a horizontal line, care being taken to insert parentheses were necessary to avoid ambiguity. Exceptions are the proper fractions available as single type on keyboards and in character sets (e.g., ¼, ½, ¾).
The solidus is not generally used for units: ms-¹ not m/s, but note electrons/s, counts/channel, etc.
Displayed equations referred to in the text should be numbered serially ((1), (2), etc.) on the right-hand side of the page. Short expressions not referred to by any number will usually be incorporated in the text.
Symbols used to represent tensors, matrices, vectors, and scalar variables should either be used as required from the character set of the application you are using or marked on hard-copy by underlining with a wavy underline for bold, a straight underline for italic and a straight red underline for sans serif.
The following styles are preferred: upright bold sans serif r for tensors, bold serif italic r for vectors, upright bold serif for matrices, and medium-face sloping serif r for scalar variables. In mathematical expressions, the use of «d» for differential should be made clear and coded in roman, not italic.
Typographical requirements must be clearly indicated at their first occurrence, e.g. Greek, Roman, script, sans serif, bold, italic. Authors will be charged for corrections at proof stage resulting from a failure to do so.
Braces, brackets, and parentheses are used in the order { [( )]}, except where mathematical convention dictates otherwise (e.g. square brackets for commutators and anticommutators; braces for the exponent in exponentials
For units and symbols, the SI system should be used. Where measurements are given in other systems, conversion factors or conversions should be inserted by the author.

Submission with a special character

If your article contains special characters, accents, or diacritics, and you are preparing your manuscript in Microsoft Word, we recommend the following procedure:
For European accents, Greek, Hebrew, or Cyrillic letters, or phonetic symbols: choose Times New Roman font from the dropdown menu in the «Insert symbol» window and insert the character you require.
For Asian languages such as Sanskrit, Korean, Chinese, or Japanese: choose Arial Unicode font from the dropdown menu in the Insert symbol” window and insert the character you require.
For transliterated Arabic: you may choose either Times New Roman or Arial Unicode (unless the Instructions for Authors specify a particular font). For as and hamzas select unicode arial font from the dropdown menu in the «Insert symbol» window and then type the Unicode hexes directly into the «Character code» box. Use 02BF for ayn, and 02BE for Hamza.
Please also see the Unicode character code chart. 

Submission with footnotes

Footnotes should be used sparingly. Number them consecutively throughout the article, using Arabic superscript numbers. Many word processors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
Table footnotes: Indicate each footnote in a table with a superscript lowercase letter.
Please note that figures and supplemental material should not be included in the body of the manuscript, but rather submitted separately as individual files.
The title, authors, and affiliations should all be included on a title page as the first page of the manuscript file.
There are no explicit requirements for section organization between these beginning and ending sections. Articles may be organized in different ways and with different section titles, according to the authors’ preference and type of article. In most cases, internal sections typically include:
The introduction must not exceed 2,000 keystrokes (characters plus spaces) and briefly justifies the research, specifies the hypotheses to be tested, and gives the objective(s).

The introduction should:

  • Provide background that puts the manuscript into context and allows readers outside the field to understand the purpose and significance of the study
  • Define the problem addressed and why it is important
  • Include a brief review of the critical literature
  • Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field
  • Note any relevant controversies or disagreements in the field
  • The section should end with a very brief statement of what is being reported in the article.
  • The main and secondary objectives should be made clear, and any pre-specified subgroup analysis should be described.
  • Give only strictly pertinent references and do not include data or conclusions from the work being reported.
  • Extensive discussion of relevant literature should be included in the discussion.

Materials and methods

Sufficient information should be given to permit repetition of the experimental work. This should include the design of the study, the setting, the type of participants or materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculation if appropriate.
Specific information and/or protocols for new methods should be included in detail. If materials, methods, and protocols are well established, authors may cite articles where those protocols are described in detail, but the submission should include sufficient information to be understood independent of these references.
We encourage authors to submit detailed protocols for newer or less well-established methods as Supporting Information.
Methods sections of papers with data that should be deposited in a publicly available database should specify where the data have been deposited and provide the relevant accession numbers and version numbers, if appropriate. Accession numbers should be provided in parentheses after the entity on first use. If the accession numbers have not yet been obtained at the time of submission, please state that they will be provided during review. They must be provided prior to publication 


Present your results in logical sequence in the text or in the form of tables or figures/illustrations when feasible, giving the main or most important findings first. The text should explain or elaborate on the tabular data, but numbers should not be repeated within text. Extra or supplementary data and technical details can be placed in an appendix where it will be accessible but will not interrupt the flow of the text.
When data are summarized in the results section, sufficient data, all with some index of variation attached should be presented to allow the readers to interpret the results of the experiment. Give numeric results not only as derivatives (For example %) but also as the absolute numbers from which the derivatives were calculated and specify the statistical methods used to analyse them.
Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid non –technical uses of technical terms in statistics, such as “random” (which implies a randomizing device), “normal”, “significant”, “correlations”, a
Results section may be further divided into subsections, each with a concise subheading, as appropriate. These sections have no word limit, but the language should be clear and concise.


These sections may all be separate or may be combined to create a mixed Results/Discussion section (commonly labeled «Results and Discussion») or a mixed Discussion / Conclusions section (often labeled «Discussion»).
Emphasize the new and essential aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or the Results section. For experimental studies it is useful to begin the discussion by summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast how your research is different from previous reported and how your observations will significantly advance the current knowledge of the subject, state the limitations of the study. Do not repeat the details given in the introduction. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such.
Abbreviations should be kept to a minimum and defined upon first use in the text. Non-standard abbreviations should not be used unless they appear at least three times in the text.
Standardized nomenclature should be used as appropriate, including appropriate usage of species names and SI units.

Article Types & Format

In general, the Manuscripts are classified into following groups based on the criteria noted below. The author(s) are encouraged to request a particular classification upon submitting (please include this in the cover letter); however, the Editor and the Associate Editor retain the right to classify the manuscript as they see fit, and the authors should understand that this process is subjective to some degree. The chosen classification will appear in the printed manuscript above the manuscript title.
1. Editorial
  • Written by the Bionatura Text Editors, Associate Editors, or Invited Guest Editors on a variety of subjects of interest to the Journal readers
  • Typically shorter than one page
2. Letter to the Editor
  • Submitted by the Reader
  • Supports refutes or adds relevant information related to a previously published article
  • Authors correcting their work or responding to a critique of their article by a reader(s)
  • An abstract is not required.
  • The letter should not be divided into sections.
  • The letter will undergo peer-review similar to other articles.
3. Commentary
  • Authors suggestion (scope is open to areas beyond science/technology)
  • Reviewers recommendation
  • Represents the “perspective” or “opinion” or “hypothesis” of the author(s)
  • Amount of original data is minimal, but corroborative literature data encouraged
  • Format: Does not follow the outline of Introduction, Materials/Methods, Discussion/Conclusions, and References
4. Review
  • Authors suggestion
  • Topic is relatively broad in scope
  • Review article should be on a topic which is of interest to a wide readership.
  • Review articles should have comprehensive coverage of a topic in clear and lucid language with representative figures and images.
  • Represents an overview of published information and data from many authors and sources
  • Does not contain original data (to any great extent)
  • Abstract and keywords are a must
  • Usually includes a large number of references
5. Research
  • Follows the outline of Introduction, Materials/Methods, Discussion/Conclusions, and References
  • Supported by the significant and relevant amount of data
  • Data should have been developed by the author(s)
  • Conclusions are based primarily on the data presented and compared to the published literature
6. Technology/Application (or Case Studies)
  • Describes a particular technology or application
  • Surgical techniques, new instruments, technical innovations
  • Contains original data generated in the process of developing the technology or in support of the application
  • Supported by a significant amount of data
  • May follow the outline of Introduction, Materials/Methods, Discussion/Conclusions, and References
  • Does the article impress upon the readers a new process/ or technology?
  • Case Studies- detailed description with data of the specific implementation of an application or the solution to a given practical problem
7. Case Series
  • The Case Series section of Open Access Text reports a series of 2-6 similar cases.
  • The cases should be unusual and give a unique perspective on disease presentation, pathogenesis, diagnosis, treatment, and treatment side effects.
  • The cases should address a challenging diagnostic and/or therapeutic problem with possible solutions to help and treatment side effects.
  • The case should address a challenging diagnostic and/or therapeutic problem with possible solutions to help clinicians in managing these cases much more effectively.
  • Case series must be accompanied with a comprehensive review of the literature.
  • Abstract is required.
8. Case Reports
  • Case Reports must provide an original description of a previously unreported entity or report a new presentation of a known disease or a new perspective of the case which poses a diagnostic and therapeutic challenge.
  • Case Reports should include a comprehensive review of similar cases and state the differences between the present case and previous cases.
  • Case reports should be accompanied by clinical, radiological, and pathologic images.
Informed Patient Consent
Authors should observe high standards with respect to publication ethics as set out by the Committee on Publication Ethics (COPE) and ICMJE recommendations for reporting about patients. Patients have a right to privacy that should not be infringed without prior informed consent.
Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) has given written informed consent for publication. Informed consent for this purpose requires the patient be shown the manuscript to be published.
Identifying details should be omitted if they are not essential, but patient data should never be altered or falsified to attain anonymity. We understand that complete anonymity is difficult to achieve. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
A statement addressing informed patient consent must be included as part of the manuscript under the heading ‘Consent’.
9. Case in Images
  • For ‘Case in Images’ section, the manuscript must meet all the criteria of a case report given above with the difference that 10-25 figures can be submitted for this section (Case Report can have a maximum of 7 figures).
  • The figures may include clinical images, radiology images (USG, CT, MRI, PET, SPECT, etc.), pathology images (histopathology, cytopathology, hematopathology) or a series of images of a procedure or event.


10. Clinical Images
  • Clinical Images section includes clinical images, diagnostic or investigative images, especially images in radiology, endoscopy, pathology, and cytopathology.
  • The images should be accompanied by a brief history and case discussion followed by a conclusion.
  • Abstract is not required.
  • The Clinical Images will undergo peer review similar to other articles.
11. Policy Bridge
Articles focused on bridging scientific knowledge with policy issues, policy options, or policy analysis.
12. Conference Proceedings
This section includes the papers presented in the conference usually published in a volume.
It may be months before such information is published as a journal article, or it may never be published.
13. Announcements
Bionatura Text publishes announcements of conferences, meetings, seminars, symposia, courses, and other items. The announcements should be less the 150 words. They must be accompanied by name, address and email of a contact person.
Bionatura also welcomes Special Issues, a set of related articles addressing themes or projects of broad interest, typically 4–10 articles in each group, usually including a synthesizing Commentary. Special Issues may fall within a single knowledge domain or be cross-listed under two or more domains; in either case, a single Editor-in-Chief will be responsible for the entire Special Feature. For more information, see our Special Issues informational page.
For detailed information on structure and formatting for each article type, please see our Manuscript Preparation guidelines. 

Supplemental Material

Supporting material that cannot be included, and which is not essential for inclusion, in the full text of the manuscript, but would nevertheless benefit the reader. It should not be essential to understand the conclusions of the paper but should contain data that are additional or complementary and directly relevant to the article content.
We encourage authors to include supplementary information with their submissions whenever appropriate; for example, when the amount of material is too great to warrant inclusion in the main body of the paper, or when the material is in a format that cannot be represented in print (i.e. audio, video, three-dimensional representations, and other rich media as well as additional figures and tables). Supplemental material provides additional information that enhances the main text and is directly referenced within the text but is not critical to its assertions. Please note that atomic coordinates used to create molecular models described in a manuscript, unless deposited in a publicly available database, must be made available as Supplementary data.
Although we do not limit the number or type of supplemental material items authors may include, we do require that they provide a relevant and useful expansion of the article and that they are as well described as are figures and tables included within the body of the article. Good metadata of this material are key to discoverability and usefulness.
For detailed information on formatting and submitting supplementary information, please see our guidelines on supplemental Material & Data.

Major Datasets

A condition of publication in an Open Access Text journal is that authors are required to make materials, data, and associated protocols promptly available to others without undue qualifications. Data sets must be made freely available to readers from the date of publication and must be provided to editors and peer-reviewers at submission, to evaluate the manuscript.
A basic principle of publication is that others should be able to replicate and build upon the authors’ published claims. Therefore, we require that all significant Data sets must be made freely available to readers from the date of publication, and must be provided to editors and peer-reviewers at submission, to evaluate the manuscript, unless there are clear reasons to restrict access. Datasets should be archived in an appropriate, subject-specific public archive, or an institutional repository. The Directory of Open Access Repositories provides a searchable list of over 2,000 Open Access repositories.
For more information, please see our guidelines on Supplemental Material & Data.
Submission, Review, & Decision 

Requirements for Submission

Submissions to Bionatura must meet the following criteria to be considered for publication:
  • The submission represents work that has not been published or submitted for publication elsewhere.
  • The research carried out needs to be original and the data needs to be useful to other researchers. (we agree that it is not in our power to predict which submissions will be useful, hence we will be accepting all kinds of submissions initially, with the hopes of learning and ignoring those submissions that are not useful) An inherent principle of publication is that others should be able to replicate and build upon the authors’ published claims. The article should present the results of scientific research and the results should be repeatable.
  • Futile hypothesis and failed experiments need to have sound reasoning behind their conclusions.
  • The assurance that the experiments, statistics, and other analysis are performed to a high technical standard, are repeatable and should be described in full detail.
  • Conclusions and discussions (if any) are presented in clearly explained avoiding ambiguity and are supported by the data.
  • Importance of research in the respective field.
  • Feature Prospective, Broad area of research, Rigorous methodology, Adequate evidence for its conclusions.
  • The previous literature has been treated fairly and adequately.
  • The research meets all applicable standards for the ethics of experimentation and research integrity.
  • The authors have complied with applicable reporting standards and guidelines for data publication.
  • Avoid presenting your results with raw or unprocessed data.
  • The submission is written clearly and unambiguously in Standard English.

Submission Components

  1. Manuscripts should be submitted by one of the authors, who is listed in the manuscript while submitting the manuscript files through EMS, make sure your files are in Word format.
  2. Alternatively, you can send it to our E-mail
  3. Submitted manuscripts should typically include the following elements:
  4. Cover letter (required)
  5. Manuscript (required)
  6. Figures
  7. Tables
  8. Supplemental Material
Authors are encouraged to provide the names and contact information for 3–5 external reviewers, though Associate Editors are not obligated to use these suggestions. Authors may also indicate researchers whom they feel should not review the submission.
For more information, please see our guidelines on Manuscript Preparation.

 The Review Process

An Editor-in-Chief leads Bionatura journals and supported by an international Board of Associate Editors, comprised of respected researchers in relevant fields. We are committed to providing Elementa authors with a fair and timely review process, constructive feedback, and a supportive environment. We publish methodologically sound articles, that are worthy of inclusion in the scholarly record, and that further research and discourse in the relevant field of study.
Our goal is to make initial decisions on submissions within 21 calendar days. After acceptance, the manuscript and supporting files will be immediately processed for publication, a process taking approximately ten business days, if all supporting data are in order.

Our review process follows these steps:

  1. All manuscripts submitted to Open Access Text Journals are received by the Editorial Assistant who examines all files including cover letter, text files, images, and figures. If the files meet the technical and formatting of Open Access Text, as given in the Instructions for Authors, authors are sent an acknowledgment of the manuscript along with a Manuscript ID number.
  2. After assigning the Manuscript ID number, the manuscript is sent for editorial review and external peer review. Authors are requested to quote the manuscript ID number in all correspondences with Open Access Text journals. If the manuscript files do not meet the technical requirements of the journal, authors are sent detailed instructions about the changes required in the manuscript and asked to resubmit the files to the Editorial Office, using «Submit Revision» page.
  3. After the files pass the technical and formatting requirements; the manuscript is assigned to a Section Editor or a member of the Editorial Board.
  4. The Editor reviews the manuscript and returns the manuscripts along with the comments to the Editorial Assistant or Editorial Secretary. The editorial process gives the editors the authority to reject any manuscript, if it doesn’t meet the scientific publishing standards or is out of the scope of the journal.
  5. Based on the comments of the Editor, the manuscript is sent for the external peer review. The manuscript is usually sent to two to four expert peer reviewers. The peer reviewer’s identities are kept confidential to ensure a fair and unbiased review of every manuscript.
  6. The pertinent Editor-in-Chief will review submissions to identify those that are appropriate for a full review and assign an Associate Editor to manage the review process.
  7. The Associate Editor will select reviewers, manage the review process, and will make one of the following publication recommendations to the Editor-in-Chief:
  8. Accept without revision;
  9. Invite author(s) to revise the submission to address specific but relatively minor concerns;
  10. Invite author(s) to revise the submission to address moderate to major concerns;
  11. Reject, but indicate to the author(s) that further work might justify a resubmission; or
  12. Reject outright.
  13. If a revision is recommended, the Editorial Assistant will include, with her or his review, a short paragraph summarizing the most important issues raised by the reviewers for the author(s) to address and ask the author(s) to include a Response to Reviewers with their revision. In some cases the Editorial Assistant may seek further review from the original or other reviewers.
  14. The Editor-in-Chief will make the ultimate decision regarding publication, and communicate directly with the corresponding author on the results of the review process.
  15. After acceptance, a Production Editor will perform a technical audit of the final manuscript and supporting files, to ensure that the submission will move through the production process smoothly.
  16. After the acceptance of the manuscript, it may be edited for grammar, punctuation, style and accuracy. An edited, pre-print, proof of the manuscript with all figures, table and charts included, is sent to the corresponding author for approval. The proof will be sent as a PDF file. The authors will also be sent a proof corrections form, which the authors can use to submit any changes required in the manuscript. Please note that at this stage only the type-setting like incorrect punctuation will be corrected. It will not be possible to make any significant changes to the text or add or delete figures. The proof need to be returned to the Editorial Office within three days (72 hours).
  17. After the correction proofs are received by the Editorial Office, the final version of the manuscript is prepared for publication. During preparation for publication, HTML, PDF, XML and other formats of the manuscript are prepared. After receiving page proofs, the average time to publication is approximately four weeks. All manuscripts are published in HTML and PDF formats.
  18. To facilitate the preparation of the originals, the authors are directed to consult the uniform requirements indicated above available in:
  19. References will be cited in a number flown in order of appearance in the text according to sistema Vancouver.


Vol 9 No 2 2024